EHR

U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade

Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function.1Approval is…

2 months ago

From Clicks to Care: Greenway Health to Preview AI‑Powered Practice Automation at ENGAGE 2025

TAMPA, Fla., Oct. 8, 2025 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, prepares to unveil a transformative…

3 months ago

Fusion Health Continues Successful EHR Rollout at Tennessee Department of Correction Amid Strong Company Growth

WOODBRIDGE, N.J., Oct. 8, 2025 /PRNewswire/ -- Highlighting a period of significant momentum, Fusion Health, a leading provider of innovative…

3 months ago

Solera Senior Living Unveils Innovative Multi-Partner Care Model, Cutting Falls and Hospitalizations

Five Leading Companies Unite in Groundbreaking Approach, Driving a 57% Fall Reduction and 44% Fewer Hospitalizations at Pilot Community NEW…

3 months ago

Net Health Leverages AI Support Agent with Salesforce’s Agentforce

Initial pilot provides faster, 24/7 support to clients while allowing live agents to address higher touch, more  complex requests PITTSBURGH,…

3 months ago

Pioneering HealthIT Company RXNT to Launch Ambient IQ, a Natively-Built Ambient Listening Tool for Free

RXNT to unveil a standalone release of its popular ambient listening technology. Medical practices and clinical providers can reduce documentation…

3 months ago

Waterlily Launches “Quote-and-Apply” to Simplify Long-Term Care Insurance Shopping

AI-powered platform lets families and advisors compare policies and apply for coverage within minutes SAN FRANCISCO, Oct. 8, 2025 /PRNewswire/…

3 months ago

Leaders Named in Accountable Care and Value-Based Care Technology and Advisory Ecosystem

Black Book Survey results reveal the twenty-five firms shaping the next generation of accountable care infrastructure  released in orchestration with…

3 months ago

Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement

Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to…

3 months ago